Literature DB >> 2493930

Rediscovering monoamine oxidase inhibitors.

C Bass1, R Kerwin.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2493930      PMCID： PMC1835723          DOI： 10.1136/bmj.298.6670.345

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Towards rational therapy with monoamine oxidase inhibitors.

Authors:  P Tyrer
Journal:  Br J Psychiatry       Date:  1976-04       Impact factor: 9.319

Review 2.  The practical management of affective disorders.

Authors:  D M Shaw
Journal:  Br J Psychiatry       Date:  1977-05       Impact factor: 9.319

3.  Phenelzine in phobic anxiety: a controlled trial.

Authors:  P Tyrer; J Candy; D Kelly
Journal:  Psychol Med       Date:  1973-02       Impact factor: 7.723

4.  A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.

Authors:  D W Kay; R F Garside; T J Fahy
Journal:  Br J Psychiatry       Date:  1973-07       Impact factor: 9.319

5.  Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.

Authors:  J Rabkin; F Quitkin; W Harrison; E Tricamo; P McGrath
Journal:  J Clin Psychopharmacol       Date:  1984-10       Impact factor: 3.153

6.  Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs.

Authors:  B Blackwell; E Marley; J Price; D Taylor
Journal:  Br J Psychiatry       Date:  1967-04       Impact factor: 9.319

Review 7.  The present status of monoamine oxidase inhibitors.

Authors:  C M Pare
Journal:  Br J Psychiatry       Date:  1985-06       Impact factor: 9.319

8.  Phenelzine v imipramine in atypical depression. A preliminary report.

Authors:  M R Liebowitz; F M Quitkin; J W Stewart; P J McGrath; W Harrison; J Rabkin; E Tricamo; J S Markowitz; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1984-07

9.  Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.

Authors:  R Pohl; R Berchou; J M Rainey
Journal:  J Clin Psychopharmacol       Date:  1982-12       Impact factor: 3.153

10.  Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

Authors:  D V Sheehan; J Ballenger; G Jacobsen
Journal:  Arch Gen Psychiatry       Date:  1980-01
View more
  5 in total

Review 1.  Monoamine oxidase inhibitor update. Potential adverse food and drug interactions.

Authors:  S B Lippman; K Nash
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

2.  Rediscovering monoamine oxidase inhibitors.

Authors: 
Journal:  BMJ       Date:  1989-03-11

Review 3.  Monoamine oxidase inhibitors. An update on drug interactions.

Authors:  M G Livingston; H M Livingston
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

4.  Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.

Authors:  I Berlin; R Zimmer; H M Thiede; C Payan; T Hergueta; L Robin; A J Puech
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

5.  Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects.

Authors:  I Berlin; A Cournot; R Zimmer; A M Pedarriosse; R Manfredi; P Molinier; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.